The trust position ratio — the fiduciary balance-sheet test.

The trust position ratio is the diligence test that catches what the income statement hides. An agency holds premium it owes to carriers in trust, and the question is whether it actually has the money to pay it — a question EBITDA can't answer, because a business can post strong earnings while having quietly tapped the trust account to cover payroll. For a buyer, an out-of-trust target is a regulatory liability they'd inherit, so the trust position ratio belongs in every agency diligence, run on the balance sheet the QoE doesn't reach.

§ 01 · The formula and the thresholdWhat "in trust" means.

The formula is simple: (cash + premiums receivable) ÷ premiums payable, and it must be at least 1.0 — meaning the agency has at least enough cash and collectible receivables to cover what it owes carriers. At exactly 1.0 the position is acceptable but tight; 1.05–1.15 is healthy; and above 1.25 is over-funding, which is rare and usually reflects accounting conservatism. Below 1.0 is a trust deficit — the agency is technically insolvent on its fiduciary obligations to carriers, which state insurance regulators treat as an enforcement matter with possible license restrictions and fines. The number to ask for isn't a single snapshot but a 12-month trailing series of monthly calculations, because the trajectory beats the snapshot and exposes the distinction between a benign timing wobble and a structural problem. This tests the fiduciary balance sheet that the income-statement work in the seller-commissioned QoE can't reach.

§ 02 · The three-way reconciliationThe proof layer.

The three-way reconciliation is what turns a ratio into a diagnosis. When the trust position is below 1.0 — or even when it's tight — a buyer reconciles the three independent records of the trust account: what the bank says, what the checkbook says, and what the ledger says. If all three match, the deficit is at least honestly recorded and the question becomes one of cause and cure. If they don't match, the mismatch itself is the finding, and it sorts into three explanations of escalating seriousness — a drifted bank reconciliation (operational, fixable), a systems mapping error (also fixable), or a trust violation papered over in the accounting (a deal-threatening concealment). A buyer who runs the reconciliation knows not just that a deficit exists but why, which is what determines whether it's a closing-table adjustment or a reason to walk.

§ 03 · Three causation patternsBenign, serious, or fatal.

A trust deficit has three causation patterns, and they're not equivalent. A timing mismatch is benign — a late-month collection paired with an early-next-month carrier invoice, where the trailing three-month average stays above 1.0; it's a wobble, not a problem. Operating cash-flow stress is serious — the agency is tapping the trust account for payroll or rent, producing recurring deficits aligned with cash-flow squeezes; it signals an agency living beyond its operating means. And concealment is the most serious — journal entries papering over the gap, misclassified transactions, delayed carrier remittances, a persistent deficit combined with three-way reconciliation failures, carrier collection complaints, and suspicious adjusting entries. The pattern matters more than the number, because a 0.97 from a timing mismatch is a non-event while a 0.97 from concealment is a deal-ender. One more structural tell: an agency co-mingling premium with operating funds — rather than maintaining a dedicated trust account with separate tracking — is itself a red flag, regardless of the ratio.

§ 04 · Three remediation pathsAnd why it's M&A-critical.

The remediation path follows the severity. A small, timing-driven deficit (under 5%–10% of the trust liability) is cured with a capital injection at closing — funded at the closing table. A larger, structural, or pattern deficit warrants a price reduction equal to the cost of cure plus a risk premium — a 15% trust deficit on a $3M book is a $450K cure cost, and it should come out of the purchase price, not the buyer's post-close working capital. And a large, persistent deficit with three-way reconciliation failures suggesting concealment is a walk. The reason this test is M&A-critical is the gap it closes: the income statement and EBITDA can look strong while the balance sheet is fiduciarily insolvent, and a QoE tests the income statement while only the trust position ratio tests the fiduciary balance sheet. Skip it, and a buyer can pay full price for an agency and inherit a regulatory violation and a six-figure cure cost on day one. Run it — across a 12-month trailing window with a three-way reconciliation on any deficit — and the fiduciary exposure is priced before the wire. How this and the other financial findings hold the price is in retrade defense.

◆